PharmaShots | Incisive News in 3 Shots

Subscribe Now

Recurrent Solid Tumors

Bayer's Vitrakvi Receives MHLW's Approval for the Treatment of NTRK Fusion-Positive Advanced or Recurrent Solid Tumors

Bayer's Vitrakvi Receives MHLW's Approval for the Treatment of NTRK Fusion-Positive Advanced or Recurrent Solid Tumors

March 24, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us